Page last updated: 2024-11-02

papaverine and Cardiovascular Diseases

papaverine has been researched along with Cardiovascular Diseases in 17 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option."7.71Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002)
"The aim of this study was to evaluate the effectiveness of a progressive program for the treatment of erectile dysfunction in patients with cardiovascular disease in whom sildenafil citrate (Viagra) was not an option."3.71Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate. ( Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J, 2002)

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-199014 (82.35)18.7374
1990's0 (0.00)18.2507
2000's1 (5.88)29.6817
2010's1 (5.88)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Valipour, M1
Irannejad, H1
Emami, S1
SINGER, R1
Saihara, K1
Hamasaki, S1
Ishida, S1
Kataoka, T1
Yoshikawa, A1
Orihara, K1
Ogawa, M1
Oketani, N1
Fukudome, T1
Atsuchi, N1
Shinsato, T1
Okui, H1
Kubozono, T1
Ichiki, H1
Kuwahata, S1
Mizoguchi, E1
Fujita, S1
Takumi, T1
Ninomiya, Y1
Tomita, K1
Tei, C1
CASTILLO, E1
ESPLUGUES, J1
BUCHBORN, E1
MARTELLI, A1
BETTS, TW1
CAVALLINI, L1
LUSTOK, MJ1
Israilov, S1
Niv, E1
Livne, PM1
Shmueli, J1
Engelstein, D1
Segenreich, E1
Baniel, J1
Lafargue, P1
Kermarec, J1
Severin, SE1
DuchĂȘne-Marullaz, P1
Lavarenne, J1
Gilroy, J1
Sensing, H1
Schmechel, H1
Vacheron, A1

Reviews

1 review available for papaverine and Cardiovascular Diseases

ArticleYear
[Recent data on coronary dilators].
    Actualites pharmacologiques, 1968, Volume: 21

    Topics: Amino Alcohols; Aminophylline; Animals; Benzofurans; Cardiovascular Diseases; Cats; Coronary Disease

1968

Other Studies

16 other studies available for papaverine and Cardiovascular Diseases

ArticleYear
Papaverine, a promising therapeutic agent for the treatment of COVID-19 patients with underlying cardiovascular diseases (CVDs).
    Drug development research, 2022, Volume: 83, Issue:6

    Topics: Angiotensin-Converting Enzyme 2; Cardiovascular Diseases; COVID-19; COVID-19 Drug Treatment; Humans;

2022
About the treatment of arterial circulatory disorders with acetylcholine, Priscol, eupaverine (administered intra-arterially).
    Wiener klinische Wochenschrift, 1947, Aug-08, Volume: 59, Issue:31

    Topics: Acetylcholine; Cardiovascular Diseases; Humans; Papaverine; Tolazoline

1947
Enjoying hobbies is related to desirable cardiovascular effects.
    Heart and vessels, 2010, Volume: 25, Issue:2

    Topics: Acetylcholine; Adolescent; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Coronary Angiogr

2010
[Therapeutic effects of papaverine in cardiovascular diseases].
    Medicina espanola, 1952, Volume: 28, Issue:161

    Topics: Cardiovascular Diseases; Humans; Papaverine

1952
[Clinical experiences with parokhellin].
    Arztliche Wochenschrift, 1953, Apr-17, Volume: 8, Issue:16

    Topics: Cardiovascular Diseases; Humans; Khellin; Papaverine

1953
[Therapeutic use of papaverine nicotinate].
    Minerva medica, 1953, Nov-07, Volume: 44, Issue:89

    Topics: Cardiovascular Diseases; Humans; Niacin; Papaverine

1953
Intra-arterial therapy in occlusive vascular disease.
    British medical journal, 1954, Jun-12, Volume: 1, Issue:4875

    Topics: Cardiovascular Diseases; Humans; Intermittent Claudication; Papaverine; Peripheral Vascular Diseases

1954
[Therapeutic activity of choline theophyllinate associated with papaverine trichlorohydroxyethyl-p-aminobenzoate].
    Minerva medica, 1958, Mar-07, Volume: 49, Issue:19

    Topics: Cardiovascular Diseases; Choline; Humans; Papaverine; para-Aminobenzoates; Theophylline

1958
Papaverine suppositories in myocardial infarction.
    Wisconsin medical journal, 1952, Volume: 51, Issue:3

    Topics: Cardiovascular Diseases; Coronary Disease; Humans; Myocardial Infarction; Papaverine; Suppositories

1952
Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
    International journal of impotence research, 2002, Volume: 14, Issue:1

    Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Cardiovascular

2002
[Importance of the determination of the erythrocyte content of 2,3-diphosphoglycerate. Influence of clinical state and therapy].
    Semaine des hopitaux. Therapeutique, 1977, Volume: 53, Issue:3

    Topics: Adult; Aged; Cardiovascular Diseases; Diphosphoglyceric Acids; Erythrocytes; Female; Humans; Male; M

1977
[Basic directions in the study of the biochemistry of the myocardium].
    Kardiologiia, 1967, Volume: 7, Issue:11

    Topics: Adaptation, Physiological; Animals; Camphor; Cardiac Glycosides; Cardiomegaly; Cardiovascular Diseas

1967
Medical management of extracranial vascular disease: indications and results.
    Cardiovascular clinics, 1971, Volume: 3, Issue:1

    Topics: Arteriosclerosis; Cardiovascular Diseases; Carotid Artery Diseases; Cerebral Angiography; Cerebrovas

1971
Papaverine for cerebral and other vascular disorders.
    The Medical letter on drugs and therapeutics, 1970, Mar-20, Volume: 12, Issue:6

    Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Papaverine; Vascular Diseases

1970
[Clinical picture of primary hyperlipidemias].
    Zeitschrift fur arztliche Fortbildung, 1970, Jul-15, Volume: 64, Issue:14

    Topics: Abdomen, Acute; Aged; Analgesics; Cardiovascular Diseases; Cholesterol; Diet Therapy; Diet, Diabetic

1970
[Study of a new coronary vasodilator, theophylline-propane-sulfonate of papaverine].
    Semaine therapeutique, 1968, Volume: 44, Issue:2

    Topics: Aged; Cardiovascular Diseases; Female; Humans; Male; Middle Aged; Papaverine; Salts; Vasodilator Age

1968